ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 8
The panel reviews data presented at ELCC from EMPOWERLung1 investigating cemiplimab versus chemotherapy in patients with advanced NSCLC.
Sponsored in part by Regeneron. Content independently created by OncLive.